ZA987804B - A combination of a monoamine oxidase inhibitor and a H5-HT1b antagonists or agonist - Google Patents
A combination of a monoamine oxidase inhibitor and a H5-HT1b antagonists or agonistInfo
- Publication number
- ZA987804B ZA987804B ZA987804A ZA987804A ZA987804B ZA 987804 B ZA987804 B ZA 987804B ZA 987804 A ZA987804 A ZA 987804A ZA 987804 A ZA987804 A ZA 987804A ZA 987804 B ZA987804 B ZA 987804B
- Authority
- ZA
- South Africa
- Prior art keywords
- agonist
- combination
- monoamine oxidase
- oxidase inhibitor
- ht1b antagonists
- Prior art date
Links
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9703376A SE9703376D0 (sv) | 1997-09-18 | 1997-09-18 | A new combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA987804B true ZA987804B (en) | 1999-03-18 |
Family
ID=20408296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA987804A ZA987804B (en) | 1997-09-18 | 1998-08-27 | A combination of a monoamine oxidase inhibitor and a H5-HT1b antagonists or agonist |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6159970A (fr) |
| EP (1) | EP1014986B1 (fr) |
| JP (1) | JP2001516719A (fr) |
| KR (2) | KR20010024087A (fr) |
| CN (1) | CN1278727A (fr) |
| AR (1) | AR013503A1 (fr) |
| AT (1) | ATE270889T1 (fr) |
| AU (1) | AU752719B2 (fr) |
| BR (1) | BR9812236A (fr) |
| CA (1) | CA2302204A1 (fr) |
| DE (1) | DE69825062T2 (fr) |
| DK (1) | DK1014986T3 (fr) |
| EE (1) | EE200000146A (fr) |
| ES (1) | ES2222603T3 (fr) |
| HU (1) | HUP0100621A2 (fr) |
| ID (1) | ID25789A (fr) |
| IL (1) | IL134775A0 (fr) |
| IS (1) | IS5401A (fr) |
| MX (1) | MXPA00002616A (fr) |
| NO (1) | NO20001400L (fr) |
| PL (1) | PL339368A1 (fr) |
| PT (1) | PT1014986E (fr) |
| SE (1) | SE9703376D0 (fr) |
| SK (1) | SK2832000A3 (fr) |
| TR (1) | TR200000725T2 (fr) |
| WO (1) | WO1999013878A1 (fr) |
| ZA (1) | ZA987804B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4957948A (en) * | 1988-05-05 | 1990-09-18 | Interface, Inc. | Biocidal protective coating for heat exchanger coils |
| SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| WO2002066454A1 (fr) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Derives de chromene |
| EP1408976B3 (fr) * | 2001-07-20 | 2010-08-25 | Psychogenics Inc. | Traitement des troubles de deficit de l'attention/hyperactivite |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| US20090054453A1 (en) * | 2006-03-17 | 2009-02-26 | Lilian Alcaraz | Novel Tetralins as 5-HT6 Modulators |
| EP2089383B1 (fr) | 2006-11-09 | 2015-09-16 | Probiodrug AG | Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| MX2009009234A (es) | 2007-03-01 | 2009-12-01 | Probiodrug Ag | Uso nuevo de inhibidores de ciclasa de glutaminilo. |
| WO2008128985A1 (fr) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Dérivés de thio-urée utilisés comme inhibiteurs de la glutaminyl cyclase |
| KR101755737B1 (ko) | 2009-09-11 | 2017-07-07 | 프로비오드룩 아게 | 글루타미닐 사이클라제의 억제제로서 헤테로사이클릭 유도체 |
| US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| CA2789440C (fr) | 2010-03-10 | 2020-03-24 | Probiodrug Ag | Inhibiteurs heterocycliques de la glutaminyl cyclase (qc, ec 2.3.2.5) |
| JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| WO2020183011A1 (fr) | 2019-03-14 | 2020-09-17 | Institut Curie | Inhibiteurs de htr1d et leurs utilisations dans le traitement du cancer |
| CN110179988A (zh) * | 2019-07-10 | 2019-08-30 | 王大伟 | 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0533268B1 (fr) * | 1991-09-18 | 2001-08-16 | Glaxo Group Limited | Dérivés de benzanilide comme 5-HT1D antagonistes |
| GB9119932D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
-
1997
- 1997-09-18 SE SE9703376A patent/SE9703376D0/xx unknown
-
1998
- 1998-08-27 ZA ZA987804A patent/ZA987804B/xx unknown
- 1998-09-09 MX MXPA00002616A patent/MXPA00002616A/es unknown
- 1998-09-09 PT PT98944376T patent/PT1014986E/pt unknown
- 1998-09-09 EE EEP200000146A patent/EE200000146A/xx unknown
- 1998-09-09 HU HU0100621A patent/HUP0100621A2/hu unknown
- 1998-09-09 IL IL13477598A patent/IL134775A0/xx unknown
- 1998-09-09 ID IDW20000522D patent/ID25789A/id unknown
- 1998-09-09 SK SK283-2000A patent/SK2832000A3/sk unknown
- 1998-09-09 WO PCT/SE1998/001602 patent/WO1999013878A1/fr active IP Right Grant
- 1998-09-09 US US09/171,578 patent/US6159970A/en not_active Expired - Fee Related
- 1998-09-09 BR BR9812236-3A patent/BR9812236A/pt not_active IP Right Cessation
- 1998-09-09 AU AU91931/98A patent/AU752719B2/en not_active Ceased
- 1998-09-09 KR KR1020007002835A patent/KR20010024087A/ko active Search and Examination
- 1998-09-09 KR KR1020007002830A patent/KR20010024084A/ko not_active Application Discontinuation
- 1998-09-09 CN CN98811114A patent/CN1278727A/zh active Pending
- 1998-09-09 TR TR2000/00725T patent/TR200000725T2/xx unknown
- 1998-09-09 ES ES98944376T patent/ES2222603T3/es not_active Expired - Lifetime
- 1998-09-09 PL PL98339368A patent/PL339368A1/xx unknown
- 1998-09-09 DE DE69825062T patent/DE69825062T2/de not_active Expired - Fee Related
- 1998-09-09 EP EP98944376A patent/EP1014986B1/fr not_active Expired - Lifetime
- 1998-09-09 CA CA002302204A patent/CA2302204A1/fr not_active Abandoned
- 1998-09-09 DK DK98944376T patent/DK1014986T3/da active
- 1998-09-09 AT AT98944376T patent/ATE270889T1/de not_active IP Right Cessation
- 1998-09-09 JP JP2000511500A patent/JP2001516719A/ja active Pending
- 1998-09-17 AR ARP980104635A patent/AR013503A1/es unknown
-
2000
- 2000-03-14 IS IS5401A patent/IS5401A/is unknown
- 2000-03-17 NO NO20001400A patent/NO20001400L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE9703376D0 (sv) | 1997-09-18 |
| TR200000725T2 (tr) | 2000-08-21 |
| KR20010024087A (ko) | 2001-03-26 |
| ATE270889T1 (de) | 2004-07-15 |
| AU9193198A (en) | 1999-04-05 |
| WO1999013878A1 (fr) | 1999-03-25 |
| DE69825062T2 (de) | 2005-08-25 |
| CA2302204A1 (fr) | 1999-03-25 |
| IL134775A0 (en) | 2001-04-30 |
| AR013503A1 (es) | 2000-12-27 |
| NO20001400L (no) | 2000-05-05 |
| SK2832000A3 (en) | 2000-09-12 |
| IS5401A (is) | 2000-03-14 |
| EE200000146A (et) | 2001-02-15 |
| ID25789A (id) | 2000-11-02 |
| DE69825062D1 (de) | 2004-08-19 |
| ES2222603T3 (es) | 2005-02-01 |
| PT1014986E (pt) | 2004-10-29 |
| EP1014986A1 (fr) | 2000-07-05 |
| DK1014986T3 (da) | 2004-10-25 |
| BR9812236A (pt) | 2000-07-18 |
| KR20010024084A (ko) | 2001-03-26 |
| EP1014986B1 (fr) | 2004-07-14 |
| CN1278727A (zh) | 2001-01-03 |
| MXPA00002616A (es) | 2002-04-24 |
| NO20001400D0 (no) | 2000-03-17 |
| PL339368A1 (en) | 2000-12-18 |
| US6159970A (en) | 2000-12-12 |
| HUP0100621A2 (hu) | 2001-08-28 |
| AU752719B2 (en) | 2002-09-26 |
| JP2001516719A (ja) | 2001-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA987804B (en) | A combination of a monoamine oxidase inhibitor and a H5-HT1b antagonists or agonist | |
| EP1115389A4 (fr) | Fructosamine-oxydase: antagonistes et inhibiteurs | |
| IL134776A0 (en) | A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST | |
| EP1009415A4 (fr) | INHIBITEURS DE $g(b)-LACTAMASES ET LEURS UTILISATIONS | |
| EP1083913A4 (fr) | Inhibiteurs de monoamine oxydase (mao) et leurs utilisations | |
| PL337781A1 (en) | Antagonists and reverse antagonists of glucogene | |
| HUP0101809A3 (en) | Inhibitors of type 5 and type 3 17betha-hydroxysteroid dehydrogenase and methods for their use | |
| AU2764797A (en) | Somatostatin agonists and antagonists | |
| HK1124339A1 (en) | 20-keto-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal activity 20--11- | |
| PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
| PL335054A1 (en) | Combination of agents for inhibiting carcinogenesis comprising benzimidazole and possibly a potentiator | |
| HUP9801227A3 (en) | Pharmaceutical compositions comprising monoamine oxidase b inhibitors and their use | |
| PL341335A1 (en) | Combination of ace and mmp inhibitors | |
| EP1069901A4 (fr) | Composes calcilytiques et leur utilisation | |
| ZA9810272B (en) | Formulation of a cobination of a opioid and a alpha-adrenergic agonist and the use thereof | |
| GB2338014B (en) | Novel drilling device and method of use | |
| AU6417198A (en) | Cytoprotective agents comprising monoamine oxidase inhibitors | |
| EP1023269A4 (fr) | Agonistes de beta3-adrenorecepteurs, compositions d'agonistes et procedes d'utilisation | |
| AU9640698A (en) | Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate | |
| ZA9710989B (en) | Polyprolyl inhibitors of cyclophilin | |
| HK1032740A1 (en) | A combination of a selective 5-ht1a antagonist and a selective h5-ht1b antagonist or partial agonist | |
| HUP0201880A3 (en) | Pharmaceutical composition containing sibutramine and a lipase inhibitor | |
| SI1021183T1 (en) | A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST | |
| GB9700233D0 (en) | Use of glycosidase inhibitors | |
| SI1014985T1 (en) | A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist |